MEDICIS PHARMACEUTICAL CORPORATION
Patent Owner
Stats
- 106 US PATENTS IN FORCE
- 4 US APPLICATIONS PENDING
- May 09, 2017 most recent publication
Details
- 106 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 5,115 Total Citation Count
- Dec 30, 1987 Earliest Filing
- 77 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2014/0274,982 TOPICAL COMPOSITIONS OF FLUNISOLIDE AND METHODS OF TREATMENTMar 14, 14Sep 18, 14[A61K]
2012/0238,913 METHODS OF EVALUATING NORMALCY OF LIPS AND SAFETY OF LIP TREATMENTSMar 15, 12Sep 20, 12[A61B, A61M]
2011/0319,811 COMBINATION THERAPY WITH CRYOSURGERY AND LOW DOSAGE STRENGTH IMIQUIMOD TO TREAT ACTINIC KERATOSISJun 24, 11Dec 29, 11[A61M]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9642998 Pump systems and methods for storing and dispensing a plurality of precisely measured unit-doses of imiquimod creamMar 06, 15May 09, 17[A61K, B05B, A61M]
9492682 Combination therapy with low dosage strength imiquimod and photodynamic therapy to treat actinic keratosisSep 14, 12Nov 15, 16[A61K, A61Q, A61N]
9370509 2×2×2 week dosing regimen for treating actinic keratosis with pharmaceutical compositions formulated with 3.75 % imiquimodAug 06, 12Jun 21, 16[A61K]
9271973 Methods of treating dermatological disorders and inducing interferon biosynthesis with shorter durations of imiquimod therapyNov 27, 13Mar 01, 16[A61K]
9078889 Lower dosage strength imiquimod formulations and short dosing regimens for treating genital and perianal wartsNov 27, 13Jul 14, 15[A61K, A01N]
9072876 Pump systems and methods for storing and dispensing a plurality of precisely measured unit-doses of imiquimod creamSep 03, 10Jul 07, 15[A61K, B05B, G01F, A61M]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2014/0206,735 HIGH DOSAGE TOPICAL METRONIDAZOLE AQUEOUS-BASED GEL FORMULATIONS AND THEIR USE TO TREAT ROSACEAAbandonedDec 20, 13Jul 24, 14[A61K]
2012/0329,823 LOWER DOSAGE STRENGTH IMIQUIMOD FORMULATIONS AND SHORT DOSING REGIMENS FOR TREATING GENITAL AND PERIANAL WARTSAbandonedJun 26, 12Dec 27, 12[A61K, A61P]
2012/0329,824 LOWER DOSAGE STRENGTH IMIQUIMOD FORMULATIONS AND SHORT DOSING REGIMENS FOR TREATING GENITAL AND PERIANAL WARTSAbandonedJul 26, 12Dec 27, 12[A61K, A61P]
2012/0329,825 LOWER DOSAGE STRENGTH IMIQUIMOD FORMULATIONS AND SHORT DOSING REGIMENS FOR TREATING GENITAL AND PERIANAL WARTSAbandonedJul 26, 12Dec 27, 12[A61K, A61P]
2012/0329,835 USE OF 1-HYDROXY-2- PYRIDONES FOR THE TREATMENT OF SEBORRHEIC DERMATITISAbandonedJul 23, 12Dec 27, 12[A61K, A61P]
2012/0289,490 COMPOSITIONS AND METHODS FOR ENHANCING CORTICOSTEROID DELIVERYAbandonedJul 30, 12Nov 15, 12[A61K, A61P]
2012/0289,537 METHODS OF TREATING DERMATOLOGICAL DISORDERS AND INDUCING INTERFERON BIOSYNTHESIS WITH SHORTER DURATIONS OF IMIQUIMOD THERAPYAbandonedJul 18, 12Nov 15, 12[A61K, A61P]
2012/0264,778 METHODS OF TREATING DERMATOLOGICAL DISORDERS AND INDUCING INTERFERON BIOSYNTHESIS WITH SHORTER DURATIONS OF IMIQUIMOD THERAPYAbandonedJun 26, 12Oct 18, 12[A61K, A61P]
8242155 Method of treating actinic keratosis with 3.75% imiquimod creamWithdrawnJul 13, 11Aug 14, 12[A01N]
2012/0093,892 MINOCYCLINE ORAL DOSAGE FORMS FOR THE TREATMENT OF ACNEAbandonedDec 21, 11Apr 19, 12[A61K, A61P]
2012/0083,507 METHODS OF TREATING DERMATOLOGICAL DISORDERS AND INDUCING INTERFERON BIOSYNTHESIS WITH SHORTER DURATIONS OF IMIQUIMOD THERAPYAbandonedDec 08, 11Apr 05, 12[A61K, A61P]
2011/0263,633 UP TO SIX WEEKS TREATMENT REGIMEN FOR TREATING ACTINIC KERATOSES WITH PHARMACEUTICAL COMPOSITIONS FORMULATED WITH 2.5% IMIQUIMODAbandonedJul 08, 11Oct 27, 11[A61K, A61P]
2011/0263,634 LOWER DOSAGE STRENGTH PHARMACEUTICAL COMPOSITIONS FORMULATED WITH 2.5% IMIQUIMODAbandonedJul 08, 11Oct 27, 11[A61K, A61P]
2011/0263,636 3 x 3 x 3 WEEK DOSING REGIMEN FOR TREATING ACTINIC KERATOSIS WITH PHARMACEUTICAL COMPOSITIONS FORMULATED WITH 3.75 % IMIQUIMODAbandonedJul 17, 11Oct 27, 11[A61K, A61P]
2011/0263,637 UP TO SIX WEEKS DOSING REGIMEN FOR TREATING ACTINIC KERATOSIS WITH PHARMACEUTICAL COMPOSITIONS FORMULATED WITH 3.75% IMIQUIMODAbandonedJul 18, 11Oct 27, 11[A61K, A61P]
2011/0257,217 3 x 3 x 3 WEEK TREATMENT REGIMEN FOR TREATING ACTINIC KERATOSIS WITH PHARMACEUTICAL COMPOSITIONS FORMULATED WITH 2.5% IMIQUIMODAbandonedJul 08, 11Oct 20, 11[A61K, A61P]
2011/0257,219 LOWER DOSAGE STRENGTH PHARMACEUTICAL COMPOSITIONS FORUMLATED WITH 3.75% IMIQUIMODAbandonedJul 12, 11Oct 20, 11[A61K, A61P]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.